Abstract
Hair loss is a common complaint in the outpatient setting. Frequently, patients conduct their own research on hair loss diagnosis and treatment and are faced with a number of manufacturers' claims that their products will benefit hair loss. This paper explores the truth behind those claims of hair regrowth. We intend for this information to serve as a "consumer report" for healthcare providers and patients and to help separate some of the valid claims for hair regrowth from those that are purely fiction.
MeSH terms
-
Alopecia / therapy*
-
Azasteroids / therapeutic use
-
Dietary Supplements
-
Dutasteride
-
Enzyme Inhibitors / therapeutic use
-
Female
-
Finasteride / therapeutic use
-
Humans
-
Low-Level Light Therapy
-
Male
-
Mineralocorticoid Receptor Antagonists / therapeutic use
-
Minoxidil / therapeutic use
-
Spironolactone / therapeutic use
-
Treatment Outcome
-
Vasodilator Agents / therapeutic use
Substances
-
Azasteroids
-
Enzyme Inhibitors
-
Mineralocorticoid Receptor Antagonists
-
Vasodilator Agents
-
Spironolactone
-
Finasteride
-
Minoxidil
-
Dutasteride